1.Mirtazapine Monotherapy for Antipsychotics-refractory Psychosis in a Patient with Very-late-onset Schizophrenia-like Psychosis: A Case Report
Kanji UENO ; Makoto ISHITOBI ; Hirotaka KOSAKA ; Kei ICHIJO ; Yukihiro NAGASE
Clinical Psychopharmacology and Neuroscience 2024;22(2):387-389
Very-late-onset schizophrenia-like psychosis (VLOSLP) is a condition in which psychotic symptoms emerge after the age of 60 years. Given its heterogeneous nature, VLOSLP remains a diagnostic and therapeutic dilemma. Here, we report a case of a 68-year-old patient with psychosis refractory to antipsychotics who was successfully treated with mirtazapine monotherapy. This case suggests that mirtazapine monotherapy may be effective for the treatment of patients with antipsychotic-refractory VLOSLP.
2.Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
Keita Morikane ; Naohito Satoh ; Kanji Hatano ; Kazunori Kanouchi ; Seiji Kakehata ; Shinya Satoh ; Timothy Uyeki ; Yoshiyuki Ueno
Western Pacific Surveillance and Response 2021;12(1):69-71
We conducted a seroepidemiological study in a northern Japanese prefecture where the incidence of identified COVID-19 cases was low. In June 2020, residual sera from 1009 outpatients were tested for antibody to SARS-CoV-2 by electrochemiluminescence immunoassay. Five specimens (0.5%) tested positive, suggesting low prevalence of SARS-CoV-2 infections in this population.
Result Analysis
Print
Save
E-mail